Culture, Society & Lifestyle Press Releases

Published on January 13, 2025 - 13:00 GMT

Calidi Biotherapeutics Announces Presentation of New Data of Systemic Virotherapy RTNova Platform at the AACR Annual Meeting in ...

SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced that its abstract, titled …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on January 13, 2025 - 13:00 GMT

Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference

NEW YORK, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a transformative fertility, family building and women’s health benefits solution, today announced that the Company is participating in the 43rd Annual JP …

Distribution channels:

Published on January 13, 2025 - 13:00 GMT

Update: Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on ...

TORONTO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased …

Distribution channels:

Published on January 13, 2025 - 13:00 GMT

The Chefs’ Warehouse Announces Preliminary Fiscal Year 2025 Guidance

RIDGEFIELD, Conn., Jan. 13, 2025 (GLOBE NEWSWIRE) -- The Chefs’ Warehouse, Inc. (NASDAQ: CHEF) (the “Company” or “Chefs’”), a premier distributor of specialty food products in the United States, the Middle East, and Canada, today announced its preliminary …

Distribution channels: Culture, Society & Lifestyle, Food & Beverage Industry ...

Published on January 13, 2025 - 12:50 GMT

Silexion Therapeutics to Present SIL-204 Data in KRAS-Driven Pancreatic Cancer at the 2025 ASCO Gastrointestinal Cancers Symposium

Cayman Islands, January 13, 2025 -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced that it will be presenting a poster …

Distribution channels:

Published on January 13, 2025 - 12:50 GMT

Celestica Q4 2024 Financial Results and Conference Call Thursday, January 30, 2025

TORONTO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Celestica’s (TSX: CLS) (NYSE: CLS) fourth quarter financial results and conference call will take place on Thursday, January 30. The conference call start time is 8:00am ET. Financial results will be released …

Distribution channels:

Published on January 13, 2025 - 12:45 GMT

Lifeward Cancels Its Extraordinary General Meeting of Shareholders

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), today announced that it has cancelled its previously announced Extraordinary General Meeting of Shareholders that had …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on January 13, 2025 - 12:30 GMT

Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance

– ARCALYST® (rilonacept) 2024 net product revenue of $416.4 million (unaudited), representing ~79% year-over-year growth – – ARCALYST 2025 net product revenue expected to be $560 - $580 million – – Kiniksa expects to remain cash flow positive on an annual …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...